(Q34526137)

2 August 2017

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma (English)

1 reference

2 August 2017

1 reference

1 reference

1 reference

Kazuaki Ohkubo

1

1 reference

2 August 2017

Yuji Kato

2

1 reference

2 August 2017

Tatsuki Ichikawa

3

1 reference

2 August 2017

Yuji Kajiya

4

1 reference

2 August 2017

Yoshio Takeda

5

1 reference

2 August 2017

Shinnichirou Higashi

6

1 reference

2 August 2017

Keisuke Hamasaki

7

1 reference

2 August 2017

Kazuhiko Nakao

8

1 reference

2 August 2017

Keisuke Nakata

9

1 reference

2 August 2017

Katsumi Eguchi

10

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

2 August 2017

1 reference

2 August 2017

94

1 reference

2 August 2017

10

1 reference

2 August 2017

2663-2668

1 reference

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection

2 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

The long-term course of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Clinical potential of emerging new agents in hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Nucleoside analogues in the treatment of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10557

21 January 2018

Identifiers

DOI

10.1002/CNCR.10557

1 reference

2 August 2017

1 reference